Headshot of Megan Chacon

Megan A. Chacon

Title
Principal
Offices
San Diego, New York
Phone Numbers
  • 858-678-4318
  • 212-765-5070
    • Email
    [email protected]

    Overview

    Megan Chacon’s practice emphasizes complex patent litigation across a wide range of technologies. She has extensive experience in the life sciences and pharmaceutical fields, including Hatch-Waxman litigation.

    Megan has worked on matters involving a wide variety of pharmaceutical compounds, formulations, and treatment methods for conditions such as schizophrenia, bipolar depression, pain management, hepatitis C virus, oral testosterone therapy, and osteoporosis. Megan also has experience with biotechnology, chemicals, medical devices, and consumer products.

    Megan’s experience covers all aspects of pre-litigation due diligence and litigation, including case assessment, domestic and international document collection and production, managing fact and expert discovery teams and strategy, depositions, dispositive motions, Markman hearings, settlement strategy, and pre-trial and trial work. While Megan focuses her practice in the U.S. District Courts and has appeared in many across the country, she also has experience with the U.S. International Trade Commission.

    Prior to joining the firm, Megan practiced as a patent litigator at a leading intellectual property law firm in New York focusing on Hatch-Waxman litigation. She also served as a student judicial extern to the Honorable Clark Waddoups of the U.S. District Court for the District of Utah (2009).

    Experience

    Juno Therapeutics Inc. et al. v. Kite Pharma Inc. (C.D. Cal.): Counsel for Kite in ongoing litigation against Juno concerning Kite’s CAR-T cancer therapy YESCARTA®.

    Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharma Ltd. et al. (D. NJ): Representing Plaintiffs in Hatch-Waxman litigation over schizophrenia and bipolar depression medication LATUDA®.

    In the Matter of Certain Sleep-Disordered Breathing Treatment Mask Systems and Components Thereof — Int’l Trade Comm’n Investigation No. 337-TA-1022 (I.T.C.): Counsel for complainant ResMed in the investigation against New Zealand manufacturer Fisher & Paykel Healthcare involving two ResMed patents on CPAP masks to treat sleep apnea.

    iCeutica Inc. et al v Lupin, Ltd., et al. (D. Md.): Representing Plaintiffs in Hatch-Waxman litigation over pain medication VIVLODEX®.

    Gilead Sciences, Inc. v. AbbVie (D. Del.): Represented Plaintiff in litigation over its hepatitis C treatment HARVONI®.

    Represented Plaintiff in Hatch-Waxman litigation over ocular pain drug.

    Clarus Therapeutics, Inc. v. Lipocine Inc. (D. Del.): Represented Defendant in litigation related to Defendant’s oral testosterone therapy formulation.

    iCeutica Inc. et al v Lupin, Ltd., et al. (D. Del): Represented Plaintiffs in Hatch-Waxman litigation over pain medication ZORVOLEX®.

    Warner Chilcott Co., LLC v. Teva Pharmaceuticals USA, Inc. (D. NJ): Represented Plaintiff in Hatch-Waxman litigation over osteoporosis treatment ATELVIA® (prior to joining Fish & Richardson).

    Professional associations

    Law360 Life Sciences Editorial Advisory Board, 2020